Breaking News
Top News
-
CRISPR (CRSP) Rated Overweight on Gene Editing Growth
-
Rocket Lab (RKLB) Rated Buy on $190M Defense Contract
-
Oklo Inc (OKLO) Rated Buy on Nuclear Energy Growth
-
Why 1 Top Analyst Says Apple Is a Screaming Buy Right Now
-
The Nasdaq Is Officially in a Correction. Here’s What Investors Should Do, According to History.
-
‘We call it the walking bus’: How kids are getting to school amid ICE operations
-
GoldMining initiates drilling at São Jorge Project, Brazil
-
Police Used AI as an Investigation ‘Shortcut’ and Sent an Innocent Grandmother to Jail for 5 Months
-
Franchise or Startup: Which Fits Your Entrepreneurial Goals?
-
Premier Energies begins trial production at 5.6GW solar facility in India
-
Gold on track for worst month since 2008 as Iran war enters its fifth week
-
C3.ai (AI) Reveals Cost Cuts to Boost Growth Outlook
-
UiPath (PATH) Price Target Cut Despite Strong ARR Growth
-
Palantir (PLTR) Rated Outperform on Strong Enterprise Demand
-
Amrize (AMRZ) Rated Buy on Strong Cement Margins
-
Amentum (AMTM) Rated Buy on Strong Government Demand
-
Everus (ECG) Price Target Raised on Record Backlog Growth
-
South Bow (SOBO) Gains on Keystone Pipeline Revival
-
Versant Media (VSNT) Faces Revenue Decline After Spin-Off
-
Solventum (SOLV) Rated Buy by Jefferies After Earnings Beat
2026-02-05























